Keros Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2020 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Keros Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2020 to Q3 2024.
  • Keros Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2024 was 40.5M shares, a 35.2% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 40.5M +10.5M +35.2% Oct 31, 2024 10-Q 2024-11-06
Q2 2024 37.5M +7.86M +26.5% Jul 31, 2024 10-Q 2024-08-07
Q1 2024 36.1M +6.5M +22% May 1, 2024 10-Q 2024-05-08
Q3 2023 30M +2.42M +8.77% Oct 31, 2023 10-Q 2023-11-06
Q2 2023 29.7M +3.91M +15.2% Jul 28, 2023 10-Q 2023-08-07
Q1 2023 29.6M +5.55M +23.1% Apr 27, 2023 10-Q 2023-05-04
Q3 2022 27.5M +4.14M +17.7% Oct 27, 2022 10-Q 2022-11-03
Q2 2022 25.8M +2.42M +10.4% Jul 29, 2022 10-Q 2022-08-04
Q1 2022 24M +764K +3.28% Apr 29, 2022 10-Q 2022-05-05
Q3 2021 23.4M +3.21M +15.9% Oct 28, 2021 10-Q 2021-11-04
Q2 2021 23.3M +3.17M +15.7% Jul 27, 2021 10-Q 2021-08-05
Q1 2021 23.3M +3.12M +15.5% Mar 19, 2021 10-K 2021-03-25
Q3 2020 20.2M Nov 3, 2020 10-Q 2020-11-10
Q2 2020 20.2M Aug 7, 2020 10-Q 2020-08-13
Q1 2020 20.1M May 15, 2020 10-Q 2020-05-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.